Scaled Biolabs
@ScaledBiolabs
Followers
374
Following
521
Media
85
Statuses
342
Working at the frontier of microfluidics, automation and machine learning to accelerate the discovery and translation of next generation therapies.
San Francisco, CA
Joined September 2016
Things happening back home! We were excited to host the Chief Scientist of Queensland, Prof Paul Bertsch, at Scaled for a tour and some real talk! Thanks #tradeinvestqueensland #tiq for facilitating!
0
1
13
Dropped in @CellStemCell - Thousands of human cardiac organoids used to discover heart regeneration drugs that don't cause arrythmias. by Scaled friends Richard Mills, @jehudson85, @PorrelloER, et al.
0
1
8
RT @EricTopol: High-Performance Medicine: my @NatureMedicine review of #AI and where we're headed (open-access for….
0
474
0
Today we join with @3ScanTweets @Prellisbio and friends to showcase new cell-focused technologies for biotech #JPM19 #JPM2019.
globenewswire.com
San Francisco, Jan. 07, 2019 (GLOBE NEWSWIRE) -- 3Scan, the world’s leading 3D tissue imaging company and creators of the largest high-resolution...
0
0
3
"An efficient, scalable manufacturing process is critical". Kicking off this year's #JPM19 @alliancerm @Celgene
0
5
8
Progress on predicting #protein structures using #AI out of @DeepMindAI. ". CASP organizers have called 'unprecedented progress in the ability of computational methods to predict protein structure'".
0
1
5
CEO Drew Titmarsh delivering our approach and @PlateletBioGen announcement @SynBioBeta today #synbiobeta2018. Come chat more @indbio tonight if you're about!
0
4
12
"The agreement follows a successful pilot program that has boosted the performance economics of a critical stage of #platelet production by almost an order of magnitude." Super excited about our next chapter with @PlateletBioGen ( #synbiobeta2018.
1
3
11
We're proud to announce our latest collaboration. Working with Platelet BioGenesis (@PlateletBioGen), we will unlock a robust, economical and streamlined process for making human #Platelets! Details:
0
2
6
Brace for impact. We're proud to kick off #SynBioBeta2018 with an exciting announcement. Be sure to tune in during the "Biopharma & Healthcare" session tomorrow @SynBioBeta (Room 1, 1.40pm) to hear our CEO, Drew Titmarsh (@dmtxbio), spill the details. More info coming soon!
0
2
5
RT @SynBioBeta: Join our #synbiobeta2018 session on how #synbio has become the cutting edge in #pharma & #healthcare w/ @OxfordGenetics, @M….
0
5
0
0
0
1
RT @indbio: It was a fantastic "Regenerative Medicine" event last night with @Prellisbio @ScaledBiolabs @Convalesce_Inc at @SheppardMullin….
0
5
0
RT @junaxup: Regenerative medicine event tonight with @Prellisbio @ScaledBiolabs @Convalesce_Inc at @SheppardMullin in Palo Alto https://t.….
0
4
0
Positions open! Come work with a multidisciplinary team on the cutting edge of #microfluidics, #automation, and #machinelearning to develop next generation regenerative cell therapies. Full time salary, equity and generous time off. Apply today!
1
5
9
Want to work with a multidisciplinary team on the cutting edge of regenerative cell therapies, using microfluidics, automation, and machine learning? Check out our new openings:
0
0
3
A study of 128 drugs FDA approved between 2010-2014. "Median initiation was 1974, with a median of 25 years to the established point, 28 years to first clinical trials, and 36 years to FDA approval" via Laura McNamee (@LMac0630) et al. @PLOS #motivation
0
2
4
Nice data-driven piece. "Cancer Drug Response Profile scan: A Deep Learning Model That Predicts Drug Effectiveness from Cancer Genomic Signature" via Chang et al. @Syntekabio @SciReports
0
0
0